Glutaric aciduria type II: treatment with riboflavine, carnitine and insulin
There was a significant 24% reduction in the composite primary outcome in the semaglutide group compared with those taking placebo, with first events occurring in 5.8 versus 7.5 people per 100 person-years of follow-up, such that 20 people would need to be treated for 3 years to prevent one primary event
Eli Lilly and Novartis (speakers bureau
Both contain semaglutide, but Wegovy is authorised for weight management and Ozempic is primarily authorised for type 2 diabetes
However, if the smell is overwhelming, persistent, or accompanied by severe abdominal pain or vomiting, you should consult your healthcare provider
Whether retatrutide's additional glucagon and GIP receptor activity confers further hormonal benefits remains to be established in dedicated studies